Merck KGaA Launches Venture Capital Fund for Start-Up Biotech Firms

Merck KGaA says it has launched a venture capital fund dubbed Merck Serono Ventures, to invest in emerging biotechnology companies. The fund will support biotech start-up companies that have the potential to provide innovative products in Merck Serono’s core therapeutic areas such as neurodegenerative diseases, oncology and autoimmune & inflammatory diseases. The fund will also target companies developing innovative technologies that could enable the discovery and development of new products in Merck Serono’s core therapeutic areas. Merck Serono...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers